High Mobility Group Box‐1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
High‐mobility group box‐1 (HMGB1) is a damage‐associated molecular pattern (DAMP) increased in response to liver injury. Because HMGB1 is a ligand for the receptor for advanced glycation endproducts (RAGE), we hypothesized that induction of HMGB1 could participate in the pathogenesis of liver fibrosis though RAGE cell‐specific signaling mechanisms. Liver HMGB1 protein expression correlated with fibrosis stage in patients with chronic hepatitis C virus (HCV) infection, primary biliary cirrhosis (PBC), or alcoholic steatohepatitis (ASH). Hepatic HMGB1 protein expression and secretion increased in five mouse models of liver fibrosis attributed to drug‐induced liver injury (DILI), cholestasis, ASH, or nonalcoholic steatohepatitis (NASH). HMGB1 was up‐regulated and secreted mostly by hepatocytes and Kupffer cells (KCs) following CCl 4 treatment. Neutralization of HMGB1 protected, whereas injection of recombinant HMGB1 promoted liver fibrosis. Hmgb1 ablation in hepatocytes (Hmgb1 ΔHep) or in myeloid cells (Hmgb1 ΔMye) partially protected, whereas ablation in both (Hmgb1 ΔHepΔMye) prevented liver fibrosis in vivo. Coculture with hepatocytes or KCs from CCl 4‐injected wild‐type (WT) mice up‐regulated Collagen type I production by hepatic stellate cells (HSCs); yet, coculture with hepatocytes from CCl 4‐injected Hmgb1 ΔHep or with KCs from CCl 4‐injected Hmgb1 ΔMye mice partially blunted this effect. Rage ablation in HSCs (Rage ΔHSC) and RAGE neutralization prevented liver fibrosis. Last, we identified that HMGB1 stimulated HSC migration and signaled through RAGE to up‐regulate Collagen type I expression by activating the phosphorylated mitogen‐activated protein kinase kinase (pMEK)1/2, phosphorylated extracellular signal‐regulated kinase (pERK)1/2 and pcJun signaling pathway. Conclusion: Hepatocyte and KC‐derived HMGB1 participates in the pathogenesis of liver fibrosis by signaling through RAGE in HSCs to activate the pMEK1/2, pERK1/2 and pcJun pathway and increase Collagen type I deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056 · cited 1×
“Among the receptors HMGB1 binds to, RAGE and TLR4 are expressed in HSCs and participate in liver fibrosis.(22-34) To establish the role of HSCs’ RAGE in the effects mediated by HMGB1 in liver fibrosis, WT control, WT injected with a RAGEneutralizing Ab before CCl4, Tlr4 ΔHSC, and RageΔHSC mice were treated with CCl4 f…”
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372 · cited 1×
“Among the receptors HMGB1 binds to, RAGE and TLR4 are expressed in HSCs and participate in liver fibrosis.(22-34) To establish the role of HSCs’ RAGE in the effects mediated by HMGB1 in liver fibrosis, WT control, WT injected with a RAGEneutralizing Ab before CCl4, Tlr4 ΔHSC, and RageΔHSC mice were treated with CCl4 f…”
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151 · cited 6×
“(1,2,7-10) The receptor for advanced glycation endproducts (RAGE) is a multiligand receptor long implicated in homeostasis, development, and inflammation, is one of the main receptors for HMGB1.(11) RAGE engagement results in activation of numerous downstream signals impinging on canonical pathways that regulate trans…”
InfluentialHMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2
Yu, M., Wang, H., Ding, A., Golenbock, D. T., Latz, E., Czura, C. J., Fenton, M. J., Tracey, K. J., & Yang, H. (2006) · Shock · doi:10.1097/01.shk.0000225404.51320.82 · Cited by 832 · cited 1×
“Among the receptors HMGB1 binds to, RAGE and TLR4 are expressed in HSC and participate in liver fibrosis (22-34).”
CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune Responses
Chen, G.-Y., Tang, J., Zheng, P., & Liu, Y. (2009) · Science · doi:10.1126/science.1168988 · Cited by 786 · cited 1×
“Among the receptors HMGB1 binds to, RAGE and TLR4 are expressed in HSC and participate in liver fibrosis (22-34).”
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Miura, K., Kodama, Y., Inokuchi, S., Schnabl, B., Aoyama, T., Ohnishi, H., Olefsky, J. M., Brenner, D. A., & Seki, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.052 · Cited by 741
High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
Bianchi, M. E., & Manfredi, A. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00574.x · Cited by 600 · cited 2×
“Among the receptors HMGB1 binds to, RAGE and TLR4 are expressed in HSCs and participate in liver fibrosis.(22-34) To establish the role of HSCs’ RAGE in the effects mediated by HMGB1 in liver fibrosis, WT control, WT injected with a RAGEneutralizing Ab before CCl4, Tlr4 ΔHSC, and RageΔHSC mice were treated with CCl4 f…”
Targeting HMGB1 in inflammation
Yang, H., & Tracey, K. J. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2009.11.019 · Cited by 351
Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1
Tang, D., Shi, Y., Kang, R., Li, T., Xiao, W., Wang, H., & Xiao, X. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806540 · Cited by 312
Pathologic Features and Evolution of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
Scheuer, P. J. (1998) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)63652-5 · Cited by 106
Cited by
Mechanisms and disease consequences of nonalcoholic fatty liver disease
Loomba, R., Friedman, S. L., & Shulman, G. I. (2021) · Cell · doi:10.1016/j.cell.2021.04.015 · Cited by 2,002
Liver regeneration and inflammation: from fundamental science to clinical applications
Campana, L., Esser, H., Huch, M., & Forbes, S. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00373-7 · Cited by 307
LeFort, K. R., Rungratanawanich, W., & Song, B.-J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-05061-7 · Cited by 202
“Other PTMs, such as acetylation and methylation, have been known to contribute to the progression of fibrosis in ALD [72, 195, 217, 218].”
BackgroundHepatic macrophages: Key players in the development and progression of liver fibrosis
Cheng, D., Chai, J., Wang, H., Fu, L., Peng, S., & Ni, X. (2021) · Liver International · doi:10.1111/liv.14940 · Cited by 188
Danger signals in liver injury and restoration of homeostasis
Han, H., Desert, R., Das, S., Song, Z., Athavale, D., Ge, X., & Nieto, N. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.033 · Cited by 127
Self-citation
Metadata
- Authors
- Ge, X., Arriazu, E., Magdaleno, F., Antoine, D. J., dela Cruz, R., Theise, N., & Nieto, N.
- Venue
- Hepatology
- Published
- 2018-11-13
- Volume
- 68
- Issue
- 6
- Pages
- 2380-2404
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2804552465
- Cited by
- 141
- References
- 10
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High Mobility Group Box‐1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice. https://app.cochat.ai/papers/10.1002/hep.30093
- The paper
- Ge, X., Arriazu, E., Magdaleno, F., Antoine, D. J., dela Cruz, R., Theise, N., & Nieto, N. (2018). High Mobility Group Box‐1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice. Hepatology. https://doi.org/10.1002/hep.30093
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.